Marsh (NYSE:MRSH) Receives $207.38 Average PT from Brokerages

Shares of Marsh (NYSE:MRSH) have received an average recommendation of “Hold” from the nine analysts that are presently covering the stock, Marketbeat reports. Seven analysts have rated the stock with a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $205.6250.

MRSH has been the subject of a number of recent research reports. Morgan Stanley boosted their price target on shares of Marsh from $190.00 to $195.00 and gave the stock an “equal weight” rating in a research note on Friday, January 30th. Raymond James Financial raised shares of Marsh from an “outperform” rating to a “strong-buy” rating and set a $225.00 target price for the company in a report on Tuesday, February 17th. Weiss Ratings started coverage on shares of Marsh in a research report on Thursday, January 29th. They set a “hold (c)” rating for the company. Keefe, Bruyette & Woods raised their price target on Marsh from $205.00 to $206.00 and gave the stock a “market perform” rating in a research report on Monday, February 2nd. Finally, Citigroup lifted their price objective on Marsh from $201.00 to $205.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 3rd.

Institutional Trading of Marsh

A number of hedge funds have recently modified their holdings of the company. Solstein Capital LLC bought a new stake in Marsh in the fourth quarter valued at approximately $25,000. KERR FINANCIAL PLANNING Corp acquired a new position in shares of Marsh in the 4th quarter valued at $27,000. Golden State Wealth Management LLC bought a new stake in shares of Marsh in the 4th quarter valued at $27,000. Atlas Capital Advisors Inc. acquired a new stake in Marsh during the 4th quarter worth $28,000. Finally, Ameriflex Group Inc. acquired a new stake in Marsh during the 4th quarter worth $32,000. 87.99% of the stock is currently owned by institutional investors and hedge funds.

Marsh Trading Up 0.7%

Marsh stock opened at $186.55 on Friday. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 1.20. The stock has a market capitalization of $90.31 billion, a P/E ratio of 22.13, a PEG ratio of 2.62 and a beta of 0.74. Marsh has a 12-month low of $170.37 and a 12-month high of $248.00.

Marsh (NYSE:MRSH) last announced its quarterly earnings data on Thursday, January 29th. The company reported $2.12 earnings per share for the quarter, topping the consensus estimate of $1.97 by $0.15. The firm had revenue of $6.60 billion during the quarter, compared to analysts’ expectations of $6.52 billion. Marsh had a return on equity of 31.60% and a net margin of 15.42%.The company’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period in the previous year, the business posted $1.87 EPS.

Marsh Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Thursday, April 9th will be given a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a dividend yield of 1.9%. The ex-dividend date is Thursday, April 9th. Marsh’s payout ratio is presently 42.70%.

Key Stories Impacting Marsh

Here are the key news stories impacting Marsh this week:

• Positive Sentiment: Morgan Sindall’s chair accepted a non‑executive board role at Marsh & McLennan, adding outside board experience that investors generally view as governance strengthening and a positive for long‑term oversight. Morgan Sindall Chair Takes New Non-Executive Role at Marsh & McLennan
• Neutral Sentiment: Independent/industry analyses comparing Marsh to peers (e.g., a critical piece on Marsh and Cheche Group) provide additional context but contain mixed conclusions rather than clear buy/sell catalysts; these are informational rather than immediate triggers. Critical Analysis: Marsh (NYSE:MRSH) and Cheche Group (NASDAQ:CCG)
• Neutral Sentiment: Several recent sports headlines reference a baseball player named Brandon Marsh — these are unrelated to Marsh & McLennan and should be disregarded when assessing MRSH. (Example sports coverage linked for clarity.) Phillies’ Brandon Marsh: Held out with hand injury
• Negative Sentiment: Mizuho reaffirmed a “neutral” rating but lowered its price target from $213 to $199, trimming expected upside and signaling slightly more conservative near‑term expectations; a lower PT can dampen momentum even though the firm left the rating unchanged. Benzinga Finviz

About Marsh

Marsh is a global insurance broker and risk advisor that helps organizations assess, manage and transfer a broad range of risks. The firm provides insurance placement and broking services for commercial and public-sector clients as well as specialty solutions for families and high-net-worth individuals. Its work focuses on identifying exposures, designing risk-transfer strategies and securing coverage from insurers and reinsurers to protect clients’ assets and operations.

Services offered by Marsh include commercial property and casualty broking, cyber and professional-liability placement, employee benefits consulting, and industry-specific specialty lines such as marine, energy and construction.